Skip to main content
SpringerLink
Log in

Neurologic Control of the Musculoskeletal System

  • Chapter
Physical Therapy of Cerebral Palsy

  • 3907 Accesses

Abstract

Children with cerebral palsy (CP) have a large variety of motor impairments, all of which are secondary to the encephalopathy. These impairments, which directly emanate from the encephalopathy and the disability that results, are well recognized as specific problems; however, the pathophysiology connecting the encephalopathy to the impairment and the disability is not well defined. The treatment goal of children with CP is to allow them to function in their environment, ideally the larger society, to the best of their abilities. These children continue to have CP, and the changes made by the medical treatment are directed at decreasing these disabilities by altering the secondary impairments. To alter the impairments in ways that decrease the disability requires that the interaction of different impairments in a given individual must be well understood. An understanding of the neurologic control of motor activity is required to place a construct around these impairments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connolly KHF. Neurophysiology and Neuropsychology of Motor Development. London: Mac Keith Press, 1997.

    Google Scholar 

  2. Gage J. Gait Analysis in Cerebral Palsy. London: Mac Keith Press, 1991.

    Google Scholar 

  3. Fahn S, Marsden CD, DeLong MR. Dystonia 3: Advances in Neurology. Philadelphia: Lippincott-Raven, 1998.

    Google Scholar 

  4. Nie J, DA Linkens. Fuzzy-Neural Control: Principles, Algorithms, and Applications. New York: Prentice Hall, 1995.

    Google Scholar 

  5. Gleick J. Chaos: Making a New Science. New York: Penguin Books, 1987.

    Google Scholar 

  6. Walsh G. Muscles, Masses, and Motion: The Physiology of Normality, Hypertonicity, Spasticity, and Rigidity. London: Mac Keith Press, 1992.

    Google Scholar 

  7. Sussman ME. The Diplegic Child: Evaluation and Management. Chicago: American Academy of Orthopaedic Surgeons, 1992.

    Google Scholar 

  8. Engsberg JR, Ross SA, Olree KS, Park TS. Ankle spasticity and strength in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 2000;42:42–7.

    PubMed  CAS  Google Scholar 

  9. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540–2.

    PubMed  CAS  Google Scholar 

  10. Sehgal N, McGuire JR. Beyond Ashworth. Electrophysiologic quantification of spasticity. Phys Med Rehabil Clin N Am 1998;9:949–79, ix.

    PubMed  CAS  Google Scholar 

  11. Lin JP, Brown JK, Walsh EG. The maturation of motor dexterity: or why Johnny can’t go any faster. Dev Med Child Neurol 1996;38:244–54.

    PubMed  CAS  Google Scholar 

  12. Dietz V, Berger W. Cerebral palsy and muscle transformation. Dev Med Child Neurol 1995;37:180–4.

    PubMed  CAS  Google Scholar 

  13. Ziv I, Blackburn N, Rang M, Koreska J. Muscle growth in normal and spastic mice. Dev Med Child Neurol 1984;26:94–9.

    PubMed  CAS  Google Scholar 

  14. Castle ME, Reyman TA, Schneider M. Pathology of spastic muscle in cerebral palsy. Clin Orthop 1979:223–32.

    Google Scholar 

  15. Engle AG, Franzini-Armstrong C. Myology. New York: McGraw-Hill, 1994:1936.

    Google Scholar 

  16. Miller F, Slomczykowski M, Cope R, Lipton GE. Computer modeling of the pathomechanics of spastic hip dislocation in children. J Pediatr Orthop 1999;19:486–92.

    PubMed  CAS  Google Scholar 

  17. Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. Neurology 1994;44:S44–51; discussion S51–2.

    PubMed  CAS  Google Scholar 

  18. Gracies J, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treaments. Muscle Nerve 1997;Suppl 6:S92–S120.

    Google Scholar 

  19. Erickson DL, Blacklock JB, Michaelson M, Sperling KB, Lo JN. Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 1985;16:215–7.

    PubMed  CAS  Google Scholar 

  20. Zierski J, Muller H, Dralle D, Wurdinger T. Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl 1988;43:94–9.

    CAS  Google Scholar 

  21. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy [see comments]. JAMA 1991;265:1418–22.

    PubMed  CAS  Google Scholar 

  22. Albright AL, Barry MJ, Fasick P, Barron W, Shultz B. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 1996;38:934–8; discussion 938–9.

    PubMed  CAS  Google Scholar 

  23. Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996;11:77–83.

    PubMed  CAS  Google Scholar 

  24. Almeida GL, Campbell SK, Girolami GL, Penn RD, Corcos DM. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Phys Ther 1997;77:751–64.

    PubMed  CAS  Google Scholar 

  25. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997;87:409–14.

    PubMed  CAS  Google Scholar 

  26. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996;11(suppl 1):S29–35.

    PubMed  Google Scholar 

  27. Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997;27:40–4.

    PubMed  CAS  Google Scholar 

  28. Wiens HD. Spasticity in children with cerebral palsy: a retrospective review of the effects of intrathecal baclofen. Issues Compr Pediatr Nurs 1998; 21:49–61.

    PubMed  CAS  Google Scholar 

  29. Kita M, Goodkin DE. Drugs used to treat spasticity. Drugs 2000;59:487–95.

    PubMed  CAS  Google Scholar 

  30. Bennett MI, Tai YM, Symonds JM. Staphylococcal meningitis following Synchromed intrathecal pump implant: a case report. Pain 1994;56:243–4.

    PubMed  CAS  Google Scholar 

  31. Sweet CS, Wenger HC, Gross DM. Central antihypertensive properties of muscimol and related gamma-aminobutyric acid agonists and the interaction of muscimol with baroreceptor reflexes. Can J Physiol Pharmacol 1979;57:600–5.

    PubMed  CAS  Google Scholar 

  32. Rode G, Mertens P, Beneton C, Schmitt M, Boisson D. Regression of vasomotor disorders under intrathecal baclofen in a case of spastic paraplegia. Spinal Cord 1999;37:370–2.

    PubMed  CAS  Google Scholar 

  33. Agmo A, Paredes R. GABAergic drugs and sexual behaviour in the male rat. Eur J Pharmacol 1985;112:371–8.

    PubMed  CAS  Google Scholar 

  34. Leipheimer RE, Sachs BD. GABAergic regulation of penile reflexes and copulation in rats. Physiol Behav 1988;42:351–7.

    PubMed  CAS  Google Scholar 

  35. Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebaut JB, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 1998;79:494–6.

    PubMed  CAS  Google Scholar 

  36. Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy [published erratum appears in Dev Med Child Neurol 1997;39(11): inside back cover] [see comments]. Dev Med Child Neurol 1997;39:178–84.

    PubMed  CAS  Google Scholar 

  37. McLaughlin JF, Bjornson KF, Astley SJ, et al. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial [see comments]. Dev Med Child Neurol 1998;40:220–32.

    PubMed  CAS  Google Scholar 

  38. Cohen AR, Webster HC. How selective is selective posterior rhizotomy? Surg Neurol 1991;35:267–72.

    PubMed  CAS  Google Scholar 

  39. Logigian EL, Wolinsky JS, Soriano SG, Madsen JR, Scott RM. H reflex studies in cerebral palsy patients undergoing partial dorsal rhizotomy [see comments]. Muscle Nerve 1994;17:539–49.

    PubMed  CAS  Google Scholar 

  40. Sacco DJ, Tylkowski CM, Warf BC. Nonselective partial dorsal rhizotomy: a clinical experience with 1-year follow-up. Pediatr Neurosurg 2000;32:114–8.

    PubMed  CAS  Google Scholar 

  41. Peacock WJ, Arens LJ, Berman B. Cerebral palsy spasticity. Selective posterior rhizotomy. Pediatr Neurosci 1987;13:61–6.

    PubMed  CAS  Google Scholar 

  42. Fasano VA, Broggi G, Barolat-Romana G, Sguazzi A. Surgical treatment of spasticity in cerebral palsy. Childs Brain 1978;4:289–305.

    PubMed  CAS  Google Scholar 

  43. Heimburger RF, Slominski A, Griswold P. Cervical posterior rhizotomy for reducing spasticity in cerebral palsy. J Neurosurg 1973;39:30–4.

    PubMed  CAS  Google Scholar 

  44. Benedetti A, Colombo F. Spinal surgery for spasticity (46 cases). Neurochirurgia (Stuttg) 1981;24:195–8.

    PubMed  CAS  Google Scholar 

  45. Benedetti A, Colombo F, Alexandre A, Pellegri A. Posterior rhizotomies for spasticity in children affected by cerebral palsy. J Neurosurg Sci 1982;26:179–84.

    PubMed  CAS  Google Scholar 

  46. Gul SM, Steinbok P, McLeod K. Long-term outcome after selective posterior rhizotomy in children with spastic cerebral palsy. Pediatr Neurosurg 1999;31:84–95.

    PubMed  CAS  Google Scholar 

  47. Subramanian N, Vaughan CL, Peter JC, Arens LJ. Gait before and 10 years after rhizotomy in children with cerebral palsy spasticity. J Neurosurg 1998;88:1014–9.

    PubMed  CAS  Google Scholar 

  48. Giuliani CA. Dorsal rhizotomy for children with cerebral palsy: support for concepts of motor control. Phys Ther 1991;71:248–59.

    PubMed  CAS  Google Scholar 

  49. Steinbok P, Daneshvar H, Evans D, Kestle JR. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatr Neurosurg 1995;22:255–64.

    PubMed  CAS  Google Scholar 

  50. Marty GR, Dias LS, Gaebler-Spira D. Selective posterior rhizotomy and soft-tissue procedures for the treatment of cerebral diplegia. J Bone Joint Surg [Am] 1995;77:713–8.

    PubMed  CAS  Google Scholar 

  51. Carroll KL, Moore KR, Stevens PM. Orthopedic procedures after rhizotomy. J Pediatr Orthop 1998;18:69–74.

    PubMed  CAS  Google Scholar 

  52. Crawford K, Karol LA, Herring JA. Severe lumbar lordosis after dorsal rhizotomy. J Pediatr Orthop 1996;16:336–9.

    PubMed  CAS  Google Scholar 

  53. Mooney JF III, Millis MB. Spinal deformity after selective dorsal rhizotomy in patients with cerebral palsy. Clin Orthop 1999:48–52.

    Google Scholar 

  54. Peter JC, Hoffman EB, Arens LJ, Peacock WJ. Incidence of spinal deformity in children after multiple level laminectomy for selective posterior rhizotomy. Childs Nerv Syst 1990;6:30–2.

    PubMed  CAS  Google Scholar 

  55. Peter JC, Hoffman EB, Arens LJ. Spondylolysis and spondylolisthesis after five-level lumbosacral laminectomy for selective posterior rhizotomy in cerebral palsy. Childs Nerv Syst 1993;9:285–7; discussion 287–8.

    PubMed  CAS  Google Scholar 

  56. Greene WB, Dietz FR, Goldberg MJ, Gross RH, Miller F, Sussman MD. Rapid progression of hip subluxation in cerebral palsy after selective posterior rhizotomy. J Pediatr Orthop 1991;11:494–7.

    PubMed  CAS  Google Scholar 

  57. Heim RC, Park TS, Vogler GP, Kaufman BA, Noetzel MJ, Ortman MR. Changes in hip migration after selective dorsal rhizotomy for spastic quadriplegia in cerebral palsy. J Neurosurg 1995;82:567–71.

    PubMed  CAS  Google Scholar 

  58. Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatr Neurosurg 1998;28:300–13.

    PubMed  CAS  Google Scholar 

  59. Cobb MA, Boop FA. Replacement laminoplasty in selective dorsal rhizotomy: possible protection against the development of musculoskeletal pain. Pediatr Neurosurg 1994;21:237–42.

    PubMed  CAS  Google Scholar 

  60. Payne LZ, DeLuca PA. Heterotopic ossification after rhizotomy and femoral osteotomy. J Pediatr Orthop 1993;13:733–8.

    PubMed  CAS  Google Scholar 

  61. Abbott R. Complications with selective posterior rhizotomy. Pediatr Neurosurg 1992;18:43–7.

    PubMed  CAS  Google Scholar 

  62. Cooper IS, Upton AR, Rappaport ZH, Amin I. Correlation of clinical and physiological effects of cerebellar stimulation. Acta Neurochir Suppl 1980;30:339–44.

    CAS  Google Scholar 

  63. Davis R, Schulman J, Delehanty A. Cerebellar stimulation for cerebral palsy—double blind study. Acta Neurochir Suppl 1987;39:126–8.

    CAS  Google Scholar 

  64. Schulman JH, Davis R, Nanes M. Cerebellar stimulation for spastic cerebral palsy: preliminary report; on-going double blind study. Pacing Clin Electrophysiol 1987;10:226–31.

    PubMed  CAS  Google Scholar 

  65. Barolat G. Experience with 509 plate electrodes implanted epidurally from C1 to L1. Stereotact Funct Neurosurg 1993;61:60–79.

    PubMed  CAS  Google Scholar 

  66. Hugenholtz H, Humphreys P, McIntyre WM, Spasoff RA, Steel K. Cervical spinal cord stimulation for spasticity in cerebral palsy. Neurosurgery 1988;22:707–14.

    PubMed  CAS  Google Scholar 

  67. Cusick JF, Larson SJ, Sances A. The effect of T-myelotomy on spasticity. Surg Neurol 1976;6:289c92.

    Google Scholar 

  68. Ivan LP, Wiley JJ. Myelotomy in the management of spasticity. Clin Orthop 1975:52–6.

    Google Scholar 

  69. Padovani R, Tognetti F, Pozzati E, Servadei F, Laghi D, Gaist G. The treatment of spasticity by means of dorsal longitudinal myelotomy and lozenge-shaped griseotomy. Spine 1982;7:103–9.

    PubMed  CAS  Google Scholar 

  70. Carpenter EB. Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic. Foot Ankle 1983;4:164–6.

    PubMed  CAS  Google Scholar 

  71. Gracies JM, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part I: Local treatments. Muscle Nerve Suppl 1997;6:S61–91.

    PubMed  CAS  Google Scholar 

  72. Carpenter EB, Seitz DG. Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 1980;22:497–501.

    PubMed  CAS  Google Scholar 

  73. Hariga J. Treatment of spasticity by alcohol injection. Dev Med Child Neurol 1970;12:825.

    PubMed  CAS  Google Scholar 

  74. Tardieu G, Tardieu C, Hariga J, Gagnard L. Treatment of spasticity in injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol 1968;10:555–68.

    PubMed  CAS  Google Scholar 

  75. Easton JK, Ozel T, Halpern D. Intramuscular neurolysis for spasticity in children. Arch Phys Med Rehabil 1979;60:155–8.

    PubMed  CAS  Google Scholar 

  76. Griffith ER, Melampy CN. General anesthesia use in phenol intramuscular neurolysis in young children with spasticity. Arch Phys Med Rehabil 1977;58:154–7.

    PubMed  CAS  Google Scholar 

  77. Matsuo T, Tada S, Hajime T. Insufficiency of the hip adductor after anterior obturator neurectomy in 42 children with cerebral palsy. J Pediatr Orthop 1986;6:686–92.

    PubMed  CAS  Google Scholar 

  78. Root L, Spero CR. Hip adductor transfer compared with adductor tenotomy in cerebral palsy. J Bone Joint Surg [Am] 1981;63:767–72.

    PubMed  CAS  Google Scholar 

  79. Sharma S, Mishra KS, Dutta A, Kulkarni SK, Nair MN. Intrapelvic obturator neurectomy in cerebral palsy. Indian J Pediatr 1989;56:259–65.

    PubMed  CAS  Google Scholar 

  80. Keenan MA, Todderud EP, Henderson R, Botte M. Management of intrinsic spasticity in the hand with phenol injection or neurectomy of the motor branch of the ulnar nerve. J Hand Surg [Am] 1987;12:734–9.

    CAS  Google Scholar 

  81. Doute DA, Sponseller PD, Tolo VT, Atkins E, Silberstein CE. Soleus neurectomy for dynamic ankle equinus in children with cerebral palsy. Am J Orthop 1997;26:613–6.

    PubMed  CAS  Google Scholar 

  82. Nogen AG. Medical treatment for spasticity in children with cerebral palsy. Childs Brain 1976;2:304–8.

    PubMed  CAS  Google Scholar 

  83. Pinder RM, Brogden RN, Speight TM, Avery GS. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 1977;13:3–23.

    PubMed  CAS  Google Scholar 

  84. Joynt RL, Leonard JA Jr. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Dev Med Child Neurol 1980;22:755–67.

    PubMed  CAS  Google Scholar 

  85. Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 1997;6:S129–45.

    PubMed  CAS  Google Scholar 

  86. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997;6:S146–68.

    PubMed  CAS  Google Scholar 

  87. Brin MF. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl 1997;6:S208–20.

    PubMed  CAS  Google Scholar 

  88. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9:31–9.

    PubMed  CAS  Google Scholar 

  89. Barwood S, Baillieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000;42:116–21.

    PubMed  CAS  Google Scholar 

  90. Greene PE, Fahn S. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Mov Disord 1993;8:479–83.

    PubMed  CAS  Google Scholar 

  91. Koman LA, Mooney JF III, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993;13:489–95.

    PubMed  CAS  Google Scholar 

  92. Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy [see comments]. J Pediatr 2000;137:331–7.

    PubMed  CAS  Google Scholar 

  93. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67–79.

    PubMed  CAS  Google Scholar 

  94. Tarczynska M, Karski T, Abobaker S. [Hip dislocation in children with cerebral palsy-the result of illness or treatment error]. Ann Univ Mariae Curie Sklodowska [Med] 1997;52:95–102.

    CAS  Google Scholar 

  95. Crenshaw S, Herzog R, Castagno P, et al. The efficacy of tone-reducing features in orthotics on the gait of children with spastic diplegic cerebral palsy. J Pediatr Orthop 2000;20:210–6.

    PubMed  CAS  Google Scholar 

  96. Radtka SA, Skinner SR, Dixon DM, Johanson ME. A comparison of gait with solid, dynamic, and no ankle-foot orthoses in children with spastic cerebral palsy [see comments] [published erratum appears in Phys Ther 1998;78(2):222–4]. Phys Ther 1997;77:395–409.

    PubMed  CAS  Google Scholar 

  97. Ricks NR, Eilert RE. Effects of inhibitory casts and orthoses on bony alignment of foot and ankle during weight-bearing in children with spasticity. Dev Med Child Neurol 1993;35:11–6.

    PubMed  CAS  Google Scholar 

  98. Bertoti DB. Effect of short leg casting on ambulation in children with cerebral palsy. Phys Ther 1986;66:1522–9.

    PubMed  CAS  Google Scholar 

  99. Cruickshank DA, O’Neill DL. Upper extremity inhibitive casting in a boy with spastic quadriplegia. Am J Occup Ther 1990;44:552–5.

    PubMed  CAS  Google Scholar 

  100. Otis JC, Root L, Kroll MA. Measurement of plantar flexor spasticity during treatment with tone-reducing casts. J Pediatr Orthop 1985;5: 682–6.

    PubMed  CAS  Google Scholar 

  101. Lesny IA. Follow-up study of hypotonic forms of cerebral palsy. Brain Dev 1979;1:87–90.

    PubMed  CAS  Google Scholar 

  102. Nelson KB, Ellenberg JH. Neonatal signs as predictors of cerebral palsy. Pediatrics 1979;64:225–32.

    PubMed  CAS  Google Scholar 

  103. Thajeb P. The syndrome of delayed posthemiplegic hemidystonia, hemiatrophy, and partial seizure: clinical, neuroimaging, and motor-evoked potential studies. Clin Neurol Neurosurg 1996;98:207–12.

    PubMed  CAS  Google Scholar 

  104. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol 1999;41:404–11.

    PubMed  CAS  Google Scholar 

  105. Ford B, Greene P, Louis ED, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol 1996;53:1241–6.

    PubMed  CAS  Google Scholar 

  106. Gros C, Frerebeau P, Perez-Dominguez E, Bazin M, Privat JM. Long term results of stereotaxic surgery for infantile dystonia and dyskinesia. Neurochirurgia (Stuttg) 1976;19:171–8.

    PubMed  CAS  Google Scholar 

  107. Lin JJ, Lin GY, Shih C, Lin SZ, Chang DC, Lee CC. Benefit of bilateral pallidotomy in the treatment of generalized dystonia. Case report. J Neurosurg 1999;90:974–6.

    PubMed  CAS  Google Scholar 

  108. Vitek JL, Chockkan V, Zhang JY, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22–35.

    PubMed  CAS  Google Scholar 

  109. Kyllerman M. Reduced optimality in pre-and perinatal conditions in dyskinetic cerebral palsy—distribution and comparison to controls. Neuropediatrics 1983;14:29–36.

    PubMed  CAS  Google Scholar 

  110. Acardi J. Diseases of the Nervous System in Childhood. Oxford, England: Mac Keith Press, 1992:1408.

    Google Scholar 

  111. O’Reilly DE, Walentynowicz JE. Etiological factors in cerebral palsy: an historical review. Dev Med Child Neurol 1981;23:633–42.

    PubMed  CAS  Google Scholar 

  112. Johnson RK, Goran MI, Ferrara MS, Poehlman ET. Athetosis increases resting metabolic rate in adults with cerebral palsy. J Am Diet Assoc 1996;96:145–8.

    PubMed  CAS  Google Scholar 

  113. Fraioli B, Nucci F, Baldassarre L. Bilateral cervical posterior rhizotomy: effects on dystonia and athetosis, on respiration and other autonomic functions. Appl Neurophysiol 1977;40:26–40.

    PubMed  Google Scholar 

  114. Davis R, Barolat-Romana G, Engle H. Chronic cerebellar stimulation for cerebral palsy-five-year study. Acta Neurochir Suppl 1980;30: 317–32.

    CAS  Google Scholar 

  115. Ebara S, Harada T, Yamazaki Y, et al. Unstable cervical spine in athetoid cerebral palsy [published erratum appears in Spine 1990; 15(1):59]. Spine 1989;14:1154–9.

    PubMed  CAS  Google Scholar 

  116. Fuji T, Yonenobu K, Fujiwara K, et al. Cervical radiculopathy or myelopathy secondary to athetoid cerebral palsy. J Bone Joint Surg [Am] 1987;69:815–21.

    PubMed  CAS  Google Scholar 

  117. Kidron D, Steiner I, Melamed E. Late-onset progressive radiculomyelopathy in patients with cervical athetoid-dystonic cerebral palsy. Eur Neurol 1987;27:164–6.

    PubMed  CAS  Google Scholar 

  118. Nishihara N, Tanabe G, Nakahara S, Imai T, Murakawa H. Surgical treatment of cervical spondylotic myelopathy complicating athetoid cerebral palsy. J Bone Joint Surg [Br] 1984;66:504–8.

    CAS  Google Scholar 

  119. Wang PY, Chen RC. Cervical spondylotic radiculomyelopathy caused by athetoid-dystonic cerebral palsy—clinical evaluation of 2 cases. Taiwan I Hsueh Hui Tsa Chih 1985;84:986–94.

    PubMed  CAS  Google Scholar 

  120. Watanuki K, Takahashi M, Ikeda T. Perception of surrounding space controls posture, gaze, and sensation during Coriolis stimulation. Aviat Space Environ Med 2000;71:381–7.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2007). Neurologic Control of the Musculoskeletal System. In: Physical Therapy of Cerebral Palsy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38305-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38305-7_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-38303-3

  • Online ISBN: 978-0-387-38305-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation